Curious about Aveanna (AVAH) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Core Viewpoint - Wall Street analysts expect Aveanna Healthcare to report a quarterly loss of $0.02 per share, indicating no change from the previous year, with revenues projected at $494.02 million, reflecting a 4.7% increase year-over-year [1] Group 1: Earnings Estimates - The consensus EPS estimate for the upcoming quarter has remained unchanged over the past 30 days, indicating analysts' reassessment of their projections [1] - Changes in earnings estimates are crucial for predicting investor reactions to the stock [1] Group 2: Revenue Projections - Analysts predict 'Revenue- PDS' will reach $396.11 million, representing a 4.9% increase from the year-ago quarter [2] - The estimate for 'Revenue- MS' is projected at $40.88 million, indicating a 5.2% increase year-over-year [2] - 'Revenue- HHH' is estimated at $55.25 million, suggesting a slight decline of 0.3% compared to the prior-year quarter [2] Group 3: Stock Performance - Aveanna's shares have returned +46.6% over the past month, contrasting with a -5.9% change in the Zacks S&P 500 composite [3] - Aveanna holds a Zacks Rank 3 (Hold), indicating expected performance in line with the overall market [3]